Global ADME Toxicology Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for ADME Toxicology Testing Market is presumed to reach the market size of nearly USD 25.79 Billion by 2032 from USD 10.27 Billion in 2023 with a CAGR of 10.77% under the study period 2024-2032.

ADME is an abbreviation in pharmacology that stands for absorption, distribution, metabolism, and elimination of chemicals and drugs to examine the impact in the human body. These four methods of testing define the impact of specific drug or chemical to the human tissue. ADME toxicology testing is an important procedure before an introduction of new drugs in the market. Such toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and consequently facilitated the performance in a pharmaceutical manufacturing company to lessen their drug discovery time, testing complications, and to minimize the cost of drug development.

MARKET DYNAMICS

The rising demand from different pharmaceutical and biotechnological organizations across the globe because of the decrease in the cost associated with different tests during the drug development process is stimulating market growth. Moreover, less time taking in the commercialization of new drug and decreasing number of drug testing failures are further pushing the market growth. However, high installation and maintenance cost along with the lack of skilled professionals to operate such a system is expected to curb market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ADME Toxicology Testing. The growth and trends of ADME Toxicology Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ADME Toxicology Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Cell Culture
High Throughput
Molecular Imaging
OMICS Technology

By Application

Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Other Toxicities

By Method

Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Global ADME Toxicology Testing Market Report market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ADME Toxicology Testing market include Thermo Fisher Scientific Inc., Promega Corp., Agilent Technologies Inc., Curia Global Inc., Dassault SysteMes, Beckman Coulter Inc., (Danaher), Catalent Inc., Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, GE HealthCare, Miltenyi Biotec, IQVIA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11210664

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ADME TOXICOLOGY TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Method
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. Cell Culture Historic and Forecast Sales By Regions
5.4. High Throughput Historic and Forecast Sales By Regions
5.5. Molecular Imaging Historic and Forecast Sales By Regions
5.6. OMICS Technology Historic and Forecast Sales By Regions

6. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Systemic Toxicity Historic and Forecast Sales By Regions
6.4. Renal Toxicity Historic and Forecast Sales By Regions
6.5. Hepatotoxicity Historic and Forecast Sales By Regions
6.6. Neurotoxicity Historic and Forecast Sales By Regions
6.7. Other Toxicities Historic and Forecast Sales By Regions

7. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY METHOD

7.1. Overview By Method
7.2. Historical and Forecast Data Analysis By Method
7.3. Cellular Assay Historic and Forecast Sales By Regions
7.4. Biochemical Assay Historic and Forecast Sales By Regions
7.5. In-Silica Historic and Forecast Sales By Regions
7.6. Ex-vivo Historic and Forecast Sales By Regions

8. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADME TOXICOLOGY TESTING COMPANIES

9.1. ADME Toxicology Testing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ADME TOXICOLOGY TESTING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Promega Corp.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Agilent Technologies Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Curia Global Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Dassault SysteMes
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Beckman Coulter Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Catalent Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Charles River Laboratories
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Labcorp Drug Development
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Eurofins Scientific
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. GE HealthCare
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Miltenyi Biotec
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. IQVIA Inc
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies